Data from UK Clinical Practice Research Datalink. Comparison of gout incidence rate in cohort diagnosed with OSA vs. cohort (matched by age, sex, practice) never diagnosed with OSA. 5.8 years median follow-up.
15,878 Diagnosed with OSA. 63,296 Never diagnosed with OSA*
Data from UK Health Improvement Network. Comparison of gout incidence rate with first SA diagnosis vs. cohort (matched by age, sex, BMI) never diagnosed with SA.
9,865 With first SA diagnosis. 43,598 Never diagnosed with SA*
SUA data show monotonic increase with AHI in those who had a cardiovascular event
N/A
* Not all subjects were tested for OSA so the numbers are likely to underrepresent the true number of subjects with OSA. SA: sleep apnea; BMI: body mass index; AHI: apnea-hypopnea index; KPyr: kiloperson-years; N/A: not applicable; SUA: serum uric acid
The author gratefully acknowledges the information gleaned from interchanges with Dr. Richard Johnson, nephrologist; Dr. Peter Delannoy, biochemist; and Dr. Steven Weintraub, pulmonologist.
Terkeltaub R, Edwards NL. Gout: diagnosis and management of gouty arthritis and hyperuricemia. Professional Communications, Inc.; 2013.
Fisher MC, Rai SK, Lu N, Zhang Y, Choi HK. The unclosing premature mortality gap in gout: a general population-based study.Ann Rheum Dis. 2017;76:1289–94. [DOI] [PubMed]
Kuo CF, Luo SF. Gout: risk of premature death in gout unchanged for years.Nat Rev Rheumatol. 2017;13:200–1. [DOI] [PubMed]
Mccormick N, Yokose C, Lin K, Lu L, Joshi A, Choi H. POS0368 Persistent premature mortality in gout: nationwide prospective cohort study.Ann Rheum Dis. 2023;82:436. [DOI]
Choi HK, Niu J, Neogi T, Chen CA, Chaisson C, Hunter D, et al. Nocturnal risk of gout attacks.Arthritis Rheumatol. 2015;67:555–62. [DOI] [PubMed] [PMC]
Marinchev L. Is the presence of sleep apnoea-hypopnoea syndrome a precursor for gout?Rheumatology (Oxford). 2013;52:1547–8. [DOI] [PubMed]
Zeng Z, Jin T, Ni J, Huang L, Xie Y, He W, et al. Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study.Semin Arthritis Rheum. 2022;57:152095. [DOI] [PubMed]
Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.Am J Med. 2012;125:679–87.e1. [DOI] [PubMed]
Bodofsky S, Merriman TR, Thomas TJ, Schlesinger N. Advances in our understanding of gout as an auto-inflammatory disease.Semin Arthritis Rheum. 2020;50:1089–100. [DOI] [PubMed]
Roddy E, Muller S, Hayward R, Mallen CD. The association of gout with sleep disorders: a cross-sectional study in primary care.BMC Musculoskelet Disord. 2013;14:119. [DOI] [PubMed] [PMC]
Zhang Y, Peloquin CE, Dubreuil M, Roddy E, Lu N, Neogi T, et al. Sleep apnea and the risk of incident gout: a population-based, body mass index-matched cohort study.Arthritis Rheumatol. 2015;67:3298–302. [DOI] [PubMed] [PMC]
Singh JA, Cleveland JD. Gout and the risk of incident obstructive sleep apnea in adults 65 years or older: an observational study.Clin Sleep Med. 2018;14:1521–7. [DOI] [PMC]
Blagojevic-Bucknall M, Mallen C, Muller S, Hayward R, West S, Choi H, et al. The risk of gout among patients with sleep apnea: a matched cohort study.Arthritis Rheumatol. 2019;71:154–60. [DOI] [PubMed]
Singh JA. Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: an internet cross-sectional survey.Arthritis Res Ther. 2019;21:36. [DOI] [PubMed] [PMC]
Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, et al. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome.Eur J Intern Med. 2014;25:471–6. [DOI] [PubMed]
Faria A, Allen AH, Fox N, Ayas N, Laher I. The public health burden of obstructive sleep apnea.Sleep Sci. 2021;14:257–65. [DOI] [PubMed] [PMC]
Cantalejo Moreira M, Veiga Cabello RM, García Díaz V, Racionero Casero MA, Zapatero Gaviria A. Gout, hyperuricaemia, sleep apnoea-hypopnoea syndrome and vascular risk.Rheumatology (Oxford). 2013;52:1619–22. [DOI] [PubMed]
Edinger JD, Ulmer CS, Means MK. Sensitivity and specificity of polysomnographic criteria for defining insomnia.J Clin Sleep Med. 2013;9:481–91. [DOI] [PubMed] [PMC]
Yu J, Sun H, Zhu J, Wei X, Shi H, Shen B, et al. Asymptomatic hyperuricemia and metabolically unhealthy obesity: a cross-sectional analysis in the Tianning Cohort.Diabetes Metab Syndr Obes. 2021;14:1367–74. [DOI] [PubMed] [PMC]
Petreski T, Ekart R, Hojs R, Bevc S. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?Ren Fail. 2020;42:978–86. [DOI] [PubMed] [PMC]
Chalès G. How should we manage asymptomatic hyperuricemia?Joint Bone Spine. 2019;86:437–43. [DOI] [PubMed]
Agabiti-Rosei E, Grassi G. Beyond gout: uric acid and cardiovascular diseases.Curr Med Res Opin. 2013;29:33–9. [DOI] [PubMed]
Simão AN, Lozovoy MA, Dichi I. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.Expert Opin Ther Targets. 2012;16:1175–87. [DOI] [PubMed]
Hasday JD, Grum CM. Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia.Am Rev Respir Dis. 1987;135:534–8. [DOI] [PubMed]
Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR. Kelley’s textbook of rheumatology. 9th ed. Elsevier; 2013.
Lin T, Huang JF, Lin QC, Chen GP, Wang BY, Zhao JM, et al. The effect of CPAP treatment on venous lactate and arterial blood gas among obstructive sleep apnea syndrome patients.Sleep Breath. 2017;21:303–9. [DOI] [PubMed]
Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, et al. Nocturnal hypoxia and loss of kidney function.PLoS One. 2011;6:e19029. [DOI] [PubMed] [PMC]
Gabryelska A, Szmyd B, Szemraj J, Stawski R, Sochal M, Białasiewicz P. Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein.J Clin Sleep Med. 2020;16:1761–8. [DOI] [PubMed] [PMC]
Liu C, Wang H, Zhu C, Wang S. Plasma expression of HIF-1α as novel biomarker for the diagnosis of obstructive sleep apnea-hypopnea syndrome.J Clin Lab Anal. 2020;34:e23545. [DOI] [PubMed] [PMC]
Kanbay M, Altıntas A, Yavuz F, Copur S, Sanchez-Lozada LG, Lanaspa MA, et al. Responses to hypoxia: how fructose metabolism and hypoxia-inducible factor-1a pathways converge in health and disease.Curr Nutr Rep. 2023;12:181–90. [DOI] [PubMed]
Mirtschink P, Krek W. Hypoxia-driven glycolytic and fructolytic metabolic programs: pivotal to hypertrophic heart disease.Biochim Biophys Acta. 2016;1863:1822–8. [DOI] [PubMed]
Mirtschink P, Krishnan J, Grimm F, Sarre A, Hörl M, Kayikci M, et al. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.Nature. 2015;522:444–9. [DOI] [PubMed] [PMC]
Nakagawa T, Lanaspa MA, Millan IS, Fini M, Rivard CJ, Sanchez-Lozada LG, et al. Fructose contributes to the Warburg effect for cancer growth.Cancer Metab. 2020;8:16. [DOI] [PubMed] [PMC]
Nakagawa T, Sanchez-Lozada LG, Andres-Hernando A, Kojima H, Kasahara M, Rodriguez-Iturbe B, et al. Endogenous fructose metabolism could explain the Warburg effect and the protection of SGLT2 inhibitors in chronic kidney disease.Front Immunol. 2021;12:694457. [DOI] [PubMed] [PMC]
Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis.Ageing Res Rev. 2021;66:101249. [DOI] [PubMed]
Renaudin F, Orliaguet L, Castelli F, Fenaille F, Prignon A, Alzaid F, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages.Ann Rheum Dis. 2020;79:1506–14. [DOI] [PubMed]
Terkeltaub RA, Dyer CA, Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo.J Clin Invest. 1991;87:20–6. [DOI] [PubMed] [PMC]
Ortiz-Bravo E, Sieck MS, Schumacher HR Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model.Arthritis Rheum. 1993;36:1274–85. [DOI] [PubMed]
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review.JAMA. 2020;323:1389–400. [DOI] [PubMed]
George C, Minter DA. Hyperuricemia. Treasure Island (FL): StatPearls Publishing; 2023.
Zhang J, Sun W, Gao F, Lu J, Li K, Xu Y, et al. Changes of serum uric acid level during acute gout flare and related factors.Front Endocrinol (Lausanne). 2023;14:1077059. [DOI] [PubMed] [PMC]
Abrams B. Viewing gout as an early symptom of sleep apnea.JSM Arthritis. 2017;2:1023.
Geovanini GR, Lorenzi-Filho G. Cardiac rhythm disorders in obstructive sleep apnea.J Thorac Dis. 2018;10:S4221–30. [DOI] [PubMed] [PMC]
Toraldo DM, De Benedetto M, Scoditti E, De Nuccio F. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.Sleep Breath. 2016;20:457–65. [DOI] [PubMed]
Bent Z, Kuck L, Sabapathy S, Sriram KB, McNamee AP, Simmonds MJ. Single-night continuous positive airway pressure treatment improves blood fluid properties in individuals recently diagnosed with obstructive sleep apnoea.Microvasc Res. 2023;148:104549. [DOI] [PubMed]
Koga S, Ikeda S, Yasunaga T, Nakata T, Maemura K. Effects of nasal continuous positive airway pressure on the glomerular filtration rate in patients with obstructive sleep apnea syndrome.Intern Med. 2013;52:345–9. [DOI] [PubMed]
Li X, Liu C, Zhang H, Zhang J, Zhao M, Sun D, et al. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease.Medicine (Baltimore). 2019;98:e14545. [DOI] [PubMed] [PMC]
Kinebuchi S, Kazama JJ, Satoh M, Sakai K, Nakayama H, Yoshizawa H, et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.Clin Sci (Lond). 2004;107:317–22. [DOI] [PubMed]
Kim D, Shim CY, Cho YJ, Park S, Lee CJ, Park JH, et al. Continuous positive airway pressure therapy restores cardiac mechanical function in patients with severe obstructive sleep apnea: a randomized, sham-controlled study.J Am Soc Echocardiogr. 2019;32:826–35. [DOI] [PubMed]
Lai S, Mordenti M, Mangiulli M, Villani T, Arcieri E, Steffanina A, et al. Resistant hypertension and obstructive sleep apnea syndrome in therapy with continuous positive airway pressure: evaluation of blood pressure, cardiovascular risk markers and exercise tolerance.Eur Rev Med Pharmacol Sci. 2019;23:9612–24. [DOI] [PubMed]
Ruzicka M, Knoll G, Leenen FHH, Leech J, Aaron SD, Hiremath S. Effects of CPAP on blood pressure and sympathetic activity in patients with diabetes mellitus, chronic kidney disease, and resistant hypertension.CJC Open. 2020;2:258–64. [DOI] [PubMed] [PMC]
Labarca G, Schmidt A, Dreyse J, Jorquera J, Enos D, Torres G, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): systematic review and meta-analysis.Sleep Med Rev. 2021;58:101446. [DOI] [PubMed]
Mesarwi OA, Loomba R, Malhotra A. Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease.Am J Respir Crit Care Med. 2019;199:830–41. [DOI] [PubMed] [PMC]
Kim D, Ahmed A, Kushida C. Continuous positive airway pressure therapy on nonalcoholic fatty liver disease in patients with obstructive sleep apnea.J Clin Sleep Med. 2018;14:1315–22. [DOI] [PubMed] [PMC]
Peker Y, Balcan B. Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea.J Thorac Dis. 2018;10:S4262–79. [PubMed] [PMC]
Park HK, Paick SH, Kim HG, Park DH, Cho JH, Hong SC, et al. Nocturia improvement with surgical correction of sleep apnea.Int Neurourol J. 2016;20:329–34. [DOI] [PubMed] [PMC]
Turner K, Zambrelli E, Lavolpe S, Baldi C, Furia F, Canevini MP. Obstructive sleep apnea: neurocognitive and behavioral functions before and after treatment.Funct Neurol. 2019;34:71–8. [PubMed]
Djonlagic I, Guo M, Igue M, Kishore D, Stickgold R, Malhotra A, et al. CPAP restores declarative memory deficit in obstructive sleep apnea.Am J Respir Crit Care Med. 2020;2023. [DOI] [PubMed] [PMC]
Velescu DR, Marc MS, Pescaru CC, Traila D, Vaștag E, Papava I, et al. Impact of CPAP therapy adherence on global cognition in patients with moderate to severe obstructive sleep apnea: a one-year follow-up.Medicina (Kaunas). 2023;59:846. [DOI] [PubMed] [PMC]
Cho JH, Suh JD, Han KD, Lee HM. Uvulopalatopharyngoplasty reduces the incidence of depression caused by obstructive sleep apnea.Laryngoscope. 2019;129:1005–9. [DOI] [PubMed]
Jackson ML, Tolson J, Schembri R, Bartlett D, Rayner G, Lee VV, et al. Does continuous positive airways pressure treatment improve clinical depression in obstructive sleep apnea? A randomized wait-list controlled study.Depress Anxiety. 2021;38:498–507. [DOI] [PubMed]
Pascual M, de Batlle J, Barbé F, Castro-Grattoni AL, Auguet JM, Pascual L, et al. Erectile dysfunction in obstructive sleep apnea patients: a randomized trial on the effects of Continuous Positive Airway Pressure (CPAP).PLoS One. 2018;13:e0201930. [DOI] [PubMed] [PMC]
Mostafa RM, Kamel NM, Elsayed EM, Saad HM. Assessment of sexual functions in male patients with obstructive sleep apnea.Am J Otolaryngol. 2021;42:102899. [DOI] [PubMed]
Schulz R, Bischof F, Galetke W, Gall H, Heitmann J, Hetzenecker A, et al.; German Sleep Apnea Research Network (GERSAN). CPAP therapy improves erectile function in patients with severe obstructive sleep apnea.Sleep Med. 2019;53:189–94. [DOI] [PubMed]
Ciccone MM, Favale S, Scicchitano P, Mangini F, Mitacchione G, Gadaleta F, et al. Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients.Int J Cardiol. 2012;158:383–6. [DOI] [PubMed]
Su J, Fang Y, Meng Y, Zhao C, Liu Y, Sun L, et al. Effect of continuous positive airway pressure on chronic cough in patients with obstructive sleep apnea and concomitant gastroesophageal reflux.Nat Sci Sleep. 2022;14:13–23. [DOI] [PubMed] [PMC]
Chen Y, Xiong L, Zeng J, Wei YG, Tan Y. Gastroesophageal reflux disease is associated with high risk of obstructive sleep apnea syndrome.Zhonghua Nei Ke Za Zhi. 2018;57:824–9. Chinese. [DOI] [PubMed]
Hadi YB, Khan AA, Naqvi SFZ, Kupec JT. Independent association of obstructive sleep apnea with Barrett’s esophagus.J Gastroenterol Hepatol. 2020;35:408–11. [DOI] [PubMed] [PMC]
Elfanagely Y, Atsawarungruangkit A, Scharfen J, Pavlech L, Moss SF. Association between obstructive sleep apnea and Barrett’s Esophagus: a systematic review and meta-analysis.Dig Dis Sci. 2021;66:3689–97. [DOI] [PubMed]
Zhu Q, Hua L, Chen L, Mu T, Dong D, Xu J, et al. Causal association between obstructive sleep apnea and gastroesophageal reflux disease: a bidirectional two-sample Mendelian randomization study.Front Genet. 2023;14:1111144. [DOI] [PubMed] [PMC]
Tsai MS, Li HY, Huang CG, Wang RYL, Chuang LP, Chen NH, et al. Risk of Alzheimer’s disease in obstructive sleep apnea patients with or without treatment: real-world evidence.Laryngoscope. 2020;130:2292–8. [DOI] [PubMed]
Lin CC, Wang HY, Liaw SF, Chiu CH, Lin MW. Effect of oral appliance on circulating leukocyte telomere length and SIRT1 in obstructive sleep apnea.Clin Oral Investig. 2019;23:1397–405. [DOI] [PubMed]
Madaeva IM, Kurashova NA, Ukhinov EB, Berdina ON, Semenova NV, Madaev VV, et al. Changes in the telomeres length in patients with obstructive sleep apnea after continuous positive airway pressure therapy: a pilot study.Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122:52–7. Russian. [DOI] [PubMed]
Lüthje L, Andreas S. Obstructive sleep apnea and coronary artery disease.Sleep Med Rev. 2008;12:19–31. [DOI] [PubMed]
Szymanski FM, Gorko D, Platek AE, Ostrowski T, Celejewski K, Chudzinski W, et al. Prevalence of obstructive sleep apnea in patients with peripheral arterial diseases.Sleep Breath. 2020;24:1035–41. [DOI] [PubMed] [PMC]
AlSheikh S. Relationship between peripheral arterial diseases and obstructive sleep apnea: a systematic review.Cureus. 2023;15:e35550. [DOI] [PubMed] [PMC]
Barros D, García-Río F. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.Sleep. 2019;42:zsy236. [DOI] [PubMed]
Yoshihisa A, Takeishi Y. Sleep disordered breathing and cardiovascular diseases.J Atheroscler Thromb. 2019;26:315–27. [DOI] [PubMed] [PMC]
Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study.Sleep Med. 2012;13:583–8. [DOI] [PubMed]
Vakil M, Park S, Broder A. The complex associations between obstructive sleep apnea and auto-immune disorders: a review.Med Hypotheses. 2018;110:138–43. [DOI] [PubMed]
Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, et al. Sleep disorders among people with migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.Headache. 2019;59:32–45. [DOI] [PubMed] [PMC]
Thavaraputta S, Dennis JA, Laoveeravat P, Nugent K, Rivas AM. Hypothyroidism and its association with sleep apnea among adults in the United States: NHANES 2007-2008.J Clin Endocrinol Metab. 2019;104:4990–7. [DOI] [PubMed]
Kheirandish-Gozal L, Gozal D. Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines.Int J Mol Sci. 2019;20:459. [DOI] [PubMed] [PMC]
Nguyen CD, Holty JC. Does untreated obstructive sleep apnea cause secondary erythrocytosis?Respir Med. 2017;130:27–34. [DOI] [PubMed]
Hilmisson H, Sveinsdottir E, Lange N, Magnusdottir S. Insomnia symptoms in primary care: a prospective study focusing on prevalence of undiagnosed co-morbid sleep disordered breathing.Eur J Intern Med. 2019;63:19–26. [DOI] [PubMed]
Pellegrini M, Bernabei F, Friehmann A, Giannaccare G. Obstructive sleep apnea and keratoconus: a systematic review and meta-analysis.Optom Vis Sci. 2020;97:9–14. [DOI] [PubMed]
Lim ZW, Wang ID, Wang P, Chung CH, Huang SS, Huang CC, et al. Obstructive sleep apnea increases risk of female infertility: a 14-year nationwide population-based study.PLoS One. 2021;16:e0260842. [DOI] [PubMed] [PMC]
Yu BE, Cheung R, Hutnik C, Malvankar-Mehta MS. Prevalence of obstructive sleep apnea in glaucoma patients: a systematic review and meta-analysis.J Curr Glaucoma Pract. 2021;15:109–16. [DOI] [PubMed] [PMC]
Hoffman K, Mansoor E, Panhwar MS, Regueiro M, Cooper G, Qazi T. Prevalence of obstructive sleep apnea is increased in patients with inflammatory bowel disease: a large, multi-network study.Crohns Colitis 360. 2022;4:otac026. [DOI] [PubMed] [PMC]
Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout.Adv Ther. 2015;32:31–41. [DOI] [PubMed] [PMC]
Khanna P, Johnson RJ, Marder B, LaMoreaux B, Kumar A. Systemic urate deposition: an unrecognized complication of gout?J Clin Med. 2020;9:3204. [DOI] [PubMed] [PMC]
Calcaianu G, Bresson D, Calcaianu M, Morisset B, El-Nazer T, Deodati C, et al. The importance of apneic events in obstructive sleep apnea associated with acute coronary syndrome.Sleep Disord. 2019;2019:6039147. [DOI] [PubMed] [PMC]
Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Morgenstern LB, et al. Sleep-disordered breathing is associated with recurrent ischemic stroke.Stroke. 2019;50:571–6. [DOI] [PubMed] [PMC]
Nacafaliyev V, Ortan P, Sayin SS. Relationship between obstructive sleep apnoea syndrome and silent brain infarction.Postgrad Med J. 2022;99:731–5. [DOI] [PubMed]
Feng Y, Zhang Z, Dong ZZ. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis.NPJ Prim Care Respir Med. 2015;25:15005. [DOI] [PubMed] [PMC]
Labarca G, Reyes T, Jorquera J, Dreyse J, Drake L. CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: systematic review and meta-analysis.Clin Respir J. 2018;12:2361–8. [DOI] [PubMed]
Sillah A, Watson NF, Schwartz SM, Gozal D, Phipps AI. Sleep apnea and subsequent cancer incidence.Cancer Causes Control. 2018;29:987–94. [DOI] [PubMed] [PMC]
Povitz M, Kendzerska T, Hanly PJ, Bray Jenkyn K, Allen B, George CFP, et al. Profile of CPAP treated patients in Ontario, Canada, 2006-2013: a population-based cohort study ☆.Sleep Med. 2018;51:22–8. [DOI] [PubMed]
Hunyor I, Cook KM. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer.Am J Physiol Regul Integr Comp Physiol. 2018;315:R669–87. [DOI] [PubMed]
Gozal D, Almendros I, Phipps AI, Campos-Rodriguez F, Martínez-García MA, Farré R. Sleep apnoea adverse effects on cancer: true, false, or too many confounders?Int J Mol Sci. 2020;21:8779. [DOI] [PubMed] [PMC]
Justeau G, Bailly S, Gervès-Pinquié C, Trzepizur W, Meslier N, Goupil F, et al.; ERMES Study Group. Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy.Eur Respir J. 2022;59:2101935. [DOI] [PubMed]
Wu D, Zhao Z, Chen C, Lu G, Wang C, Gao S, et al. Impact of obstructive sleep apnea on cancer risk: a systematic review and meta-analysis.Sleep Breath. 2023;27:843–52. [DOI] [PubMed]
Asker M, Asker S. Sleep apnea in patients with rheumatic mitral stenosis.J Heart Valve Dis. 2015;24:325–30. [PubMed]
Linhart M, Sinning JM, Ghanem A, Kozhuppakalam FJ, Fistéra R, Hammerstingl C, et al. Prevalence and impact of sleep disordered breathing in patients with severe aortic stenosis.PLoS One. 2015;10:e0133176. [DOI] [PubMed] [PMC]
Adegunsoye A, Neborak JM, Zhu D, Cantrill B, Garcia N, Oldham JM, et al. CPAP adherence, mortality, and progression-free survival in interstitial lung disease and OSA.Chest. 2020;158:1701–12. [DOI] [PubMed] [PMC]
Cheng Y, Wang Y, Dai L. The prevalence of obstructive sleep apnea in interstitial lung diseasea: a systematic review and meta-analysis.Sleep Breath. 2021;25:1219–28. [DOI] [PubMed]
Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells.Nature. 2003;425:516–21. [DOI] [PubMed]
Abrams B. Monosodium urate as a biomarker for obstructive sleep apnea.J Sleep Disord: Treat Care. 2017;6:2. [DOI]
Koppikar S, Diaz P, Kaeley GS, Eder L. Seeing is believing: smart use of musculoskeletal ultrasound in rheumatology practice.Best Pract Res Clin Rheumatol. 2023; 101850. [DOI] [PubMed]
Huang CF, Liu JC, Huang HC, Chuang SY, Chen CI, Lin KC. Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.Rheumatol Int. 2017;37:313–22. [DOI] [PubMed]
Chiang CL, Chen YT, Wang KL, Su VY, Wu LA, Perng DW, et al. Comorbidities and risk of mortality in patients with sleep apnea.Ann Med. 2017;49:377–83. [DOI] [PubMed]
Abrams B. Update on reversibility of obstructive sleep apnea consequences.Med Res Arch. 2020;8:4. [DOI]
Pérez Ruiz F, Richette P, Stack AG, Karra Gurunath R, García de Yébenes MJ, Carmona L. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.RMD Open. 2019;5:e001015. [DOI] [PubMed] [PMC]
Coburn BW, Michaud K, Bergman DA, Mikuls TR. Allopurinol dose escalation and mortality among patients with gout: a national propensity-matched cohort study.Arthritis Rheumatol. 2018;70:1298–307. [DOI] [PubMed]
Jeyaruban A, Hoy W, Cameron A, Healy H, Wang Z, Zhang J, et al. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.J Nephrol. 2021;34:753–62. [DOI] [PubMed] [PMC]
Hay CA, Prior JA, Belcher J, Mallen CD, Roddy E. Mortality in patients with gout treated with allopurinol: a systemic review and meta-analysis.Arthritis Care Res (Hoboken). 2021;73:1049–54. [DOI] [PubMed]
Gupta S, Miller E, Merkin S, McMahon M, Watson KE, FitzGerald JD. The risk of cardiovascular disease among male and female participants treated for gout in the multi-ethnic study of atherosclerosis (MESA).Gout Urate Cryst Depos Dis. 2023;1:89–98. [DOI]
Hashimoto H, Takeuchi M, Kawakami K. Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia.Clin Rheumatol. 2023;[Epub ahead of print]. [DOI] [PubMed]
Zhou Z, Ryan J, Nelson MR, Woods RL, Orchard SG, Zhu C, et al. The association of allopurinol with persistent physical disability and frailty in a large community based older cohort.J Am Geriatr Soc. 2023;[Epub ahead of print]. [DOI] [PubMed]
Stamp LK, Chapman PT. Allopurinol hypersensitivity: pathogenesis and prevention.Best Pract Res Clin Rheumatol. 2020;34:101501. [DOI] [PubMed]
White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, et al.; CARES Investigators. Cardiovascular safety of febuxostat or allopurinol in patients with gout.N Engl J Med. 2018;378:1200–10. [DOI] [PubMed]
Tsai PH, Kuo CF, Liu JR, Li PR, See LC. Effect of febuxostat on adverse events and mortality in gout in Taiwan: an interrupted time series analysis.Int J Rheum Dis. 2023;26:471–9. [DOI] [PubMed]
Goldberg A, Garcia-Arroyo F, Sasai F, Rodriguez-Iturbe B, Sanchez-Lozada LG, Lanaspa MA, et al. Mini review: Reappraisal of uric acid in chronic kidney disease.Am J Nephrol. 2021;52:837–44. [DOI] [PubMed] [PMC]
Kohagura K, Satoh A, Kochi M, Nakamura T, Zamami R, Tana T, et al. Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial.J Hypertens. 2023;[Epub ahead of print]. [DOI] [PubMed]
Coleman GB, Dalbeth N, Frampton C, Haslett J, Drake J, Su I, et al. Long-term follow-up of a randomized controlled trial of allopurinol dose escalation to achieve target serum urate in people with gout.J Rheumatol. 2022;49:1372–8. [DOI] [PubMed]
Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort.Sleep. 2008;31:1071–8. [PubMed] [PMC]
Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health study.Sleep. 2008;31:1079–85. [PubMed] [PMC]
Treatment trials needed. Family Practice News. 2008 Aug 1.
Mandal S, Kent BD. Obstructive sleep apnoea and coronary artery disease.J Thorac Dis. 2018;10:S4212–20. [DOI] [PubMed] [PMC]
Chen Q, Lin G, Chen L, Huang J, Huang Y, Li P, et al. Does continuous positive airway pressure therapy in patients with obstructive sleep apnea improves uric acid? A meta-analysis.Oxid Med Cell Longev. 2019;2019:4584936. [DOI] [PubMed] [PMC]
Shi T, Min M, Sun C, Cheng C, Zhang Y, Liang M, et al. A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea.Sleep Breath. 2019;23:1047–57. [DOI] [PubMed]
Huang QR, Qin Z, Zhang S, Chow CM. Clinical patterns of obstructive sleep apnea and its comorbid conditions: a data mining approach.J Clin Sleep Med. 2008;4:543–50. [PubMed] [PMC]